Project Grant HT94252510951
- The Department of the Army Medical Command awarded $1.59 million to Children's Hospital Medical Center under the Military Medical Research and Development program (CFDA 12.420) for the period of June 15, 2022 to June 14, 2025. The project aims to investigate whether there is a point of convergence between congenital heart disease and autism by supporting basic, applied, and advanced biomedical research to transform military and public health care. The Military Medical Research and Development...
- This federal Project Grant award of $321,981.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of California, Davis (UC Davis) on "Sensory Processing Contributions to Emotion Dysregulation and Internalizing Problems in Autism". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of how sensory...
- The federal Project Grant award of $249,999.00 was provided by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to the Children's Hospital Medical Center in Cincinnati, Ohio. The award, with a performance period from September 15, 2025 to September 14, 2027, supports the research project titled "Assessment of Smoldering Glial Activation in Pediatric-Onset MS by Novel Neuroimaging." This project aims to advance the medical...
- This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
- The Defense Health Agency awarded a $757,521 Project Grant to Oregon State University to support research on the "IMPACT OF THE GUT MICROBIOTA ON GUT SENSORY NEUROCIRCUITS IN AUTISM SPECTRUM DISORDER" under the Military Medical Research and Development program (CFDA 12.420). The project will be conducted over a period of 3 years, from July 1, 2025 to June 30, 2028. The research aims to advance scientific understanding of the relationship between the gut microbiome and sensory...
- This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,408,286.00 to the University of Texas at Dallas (UEI: EJCVPNN1WFS5) to conduct a 4-year crossover randomized controlled trial (RCT) evaluating the effectiveness of an individualized progressive treatment for expanding sound tolerance in adults with autism spectrum disorder. The research aims to transform healthcare for military service members, veterans,...
- The U.S. Defense Health Agency awarded Sunnybrook Research Institute, a Canadian non-profit research organization, a $302,500 Project Grant (CFDA 12.420 - Military Medical Research and Development) to conduct research focused on "Dissecting Biological Mechanisms Underlying Behavioral Heterogeneity in Autism." The 3-year project, running from Apr 1, 2024 to Mar 31, 2027, aims to investigate the biological underpinnings of the varied behaviors observed in individuals with autism spectrum...
- This four-year, $2.7 million Project Grant from the Department of the Army Medical Command will fund the "Regulating Together: Randomized Controlled Trial Examining Predictors, Facilitators, and Barriers to Treatment Success in Emotion Dysregulation and ASD" research project being conducted by Children's Hospital Medical Center in Cincinnati, OH. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve...
This federal Project Grant award for $321,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Children's Hospital Medical Center in Cincinnati, OH. The project, titled "MicroRNA-Induced Silencing as Treatment Target in Autism-Associated Deficits in Cortical Morphology and Behavior," aims to investigate the use of microRNA-induced silencing as a potential treatment approach for addressing autism-related deficits in cortical morphology and behavior. The award has a performance period from November 1, 2025 to October 31, 2027. This grant is part of the Defense Health Agency's broader efforts to transform healthcare for military service members, veterans, and the public through innovative biomedical research across multiple medical domains, including neuroscience and autism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $321.0k | 8/5/25 |